Form 4: Annexon Director William Waddill Granted 55,000 Stock Options

Annexon, Inc. director William D. Waddill was granted 55,000 stock options with an exercise price of $2.55, vesting over the next year or by the next annual meeting.

Summary

• William D. Waddill, a Director of Annexon, Inc. (ANNX), was granted 55,000 stock options.
• The options have an exercise price of $2.55 per share.
• The grant date for these options is June 5, 2025.
• The options will vest 100% on the earlier of June 5, 2026 (first anniversary of grant) or the next Annual Meeting following June 5, 2025.
• Vesting is contingent upon Mr. Waddill's continuous service as a director until the vesting date.
• The options expire on June 5, 2035.
• Following this transaction, Mr. Waddill beneficially owns 55,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a positive signal of alignment with shareholder interests and retention, but it's a routine compensation event rather than a major operational or financial announcement that would significantly alter the company's outlook.

Positives

• The granting of stock options to a director aligns their interests with shareholders, incentivizing long-term performance and value creation.
• The options have a 10-year expiration period (until June 5, 2035), providing a long window for potential value realization.

Risks

• The value of the stock options is dependent on the future stock price of Annexon, Inc. exceeding the exercise price of $2.55.
• Vesting of the options is subject to the director's continuous service, meaning unvested options could be forfeited if service ceases.

Future Outlook

This document is a historical report of an insider transaction and does not provide a general future outlook for the company. It only details the vesting schedule for the granted options.

Industry Context

This is a routine insider compensation disclosure common across all industries, particularly in sectors like biotech/pharma where equity compensation is a significant component of executive and director pay. It reflects standard corporate governance practices for incentivizing leadership and aligning their interests with long-term shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential positive impact as the director's interests are aligned with stock price appreciation, incentivizing decisions that enhance shareholder value.

Next Steps

• The stock options will vest on the earlier of June 5, 2026, or the next Annual Meeting following June 5, 2025, subject to continuous service.
• The director may choose to exercise these options at any time after vesting and before the expiration date of June 5, 2035, assuming the stock price is above the exercise price.

Key Dates

Recommendation

Keywords

Annexon Inc., ANNX, Form 4, SEC Filing, Insider Transaction, Stock Options, Director Compensation, Equity Grant, Beneficial Ownership